Monte Rosa Therapeutics Stock (NASDAQ: GLUE)

Monte Rosa Therapeutics (NASDAQ:GLUE) Stock, Unusual Options

Monte Rosa Therapeutics

Monte Rosa Therapeutics, Inc. - Common Stock

Overview

News

Earnings

Options

Analyst Ratings

Insider Trades

Short Interest

Stock Report

Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. With a diverse library of over 50,000 MGD molecules, their product candidate, MRT-2359, targets the translation termination factor protein GSPT1 for potential use in MYC-driven tumors. The company's focus lies in advancing its pipeline of MGDs, aiming to provide novel therapeutic modalities for various diseases.

Comments

Monte Rosa Therapeutics Unusual Options